Altered protein binding to the octamer motif appears to be an early event in programmed neuronal cell death

S Wang1, R N Pittman

  • 1Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.

Insights

Programmed neuronal cell death involves changes in transcription factor binding. A decrease in binding to octamer sequences early in the process may trigger this cell death cascade.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Neuronal cell death is a critical process in development and disease.
  • Understanding the molecular mechanisms underlying programmed neuronal cell death is essential.

Purpose of the Study:

  • To investigate changes in transcription factor binding during neuronal death.
  • To identify early molecular events that may trigger programmed neuronal cell death.

Main Methods:

  • Electrophoretic mobility-shift assays (EMSA) to analyze protein-DNA binding.
  • In vitro studies using PC12 cells and primary sympathetic neurons.
  • In vivo studies using sympathetic ganglia extracts.
  • Oligonucleotide transfection to modulate transcription factor activity.

Main Results:

  • NGF withdrawal induced distinct temporal changes in transcription factor binding to Sp1, E2F, octamer, and CRE sequences.
  • Decreased binding to octamer sequences occurred within 2 hours of NGF removal.
  • Increased binding to CRE sequences was observed after 5-7 hours.
  • Decreased binding to Sp1 sequences occurred by 14 hours.
  • In vivo studies showed similar changes in CRE and octamer binding during developmental cell death.
  • Double-stranded octamer oligonucleotides induced neuronal cell death, which was blocked by NGF.
  • Mutant or single-stranded octamer oligonucleotides had no significant effect on cell death.

Conclusions:

  • Programmed neuronal cell death is a cascade of molecular events.
  • A decrease in transcription factor binding to octamer motifs is an early event in programmed neuronal cell death.
  • This early event may initiate the cascade leading to neuronal death.

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
575
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.0K